The ESSM School of Sexual Medicine will begin October 11th in Budapest, Hungary. We're pleased to announce the names of the individuals who have been awarded ISSM scholarships for their attendance:

Dr. Mohammad Shamsul Ahsan (Bangladesh)

Dr. Rashad Mostafa Mahmoud (Egypt)

Dr. Anup Dhir (India)

Dr. Vijayasarathi Ramanathan (India)

Dr. Ahmed Al-Salih (Iraq)

Dr. Tammary Esho (Kenya)

Dr. Jawad Feghali (Lebanon)

Dr. Nansalmaa Naidan (Mongolia)

Dr. Mona Sabra (Lebanon)

Congratulations to all the awardees!

Taking tadalafil once every day could help men who have had limited success with as-needed erectile dysfunction (ED) drugs, according to American researchers.

Their study, published in July in the Journal of Sexual Medicine, included over 600 men who had had ED for at least three months. The participants' mean age was 57.6 years.

All the men had tried taking phosphodiesterase type 5 (PDE5) inhibitors on an as-needed basis and had had some success, but their erections still hadn't returned to normal.

The researchers used the International Index of Erectile Function (IIEF) to evaluate erections. A score of 26 or below indicated ED. At baseline, the men's scores ranged from 17 to 26.

After a 4-week run-in period and 4 weeks without medication, the participants were divided into three groups. The first group took 2.5 to 5 mg of tadalafil daily. The second took 5 mg of tadalafil daily and the third took a placebo.

Twelve weeks later, the researchers assessed erectile function again. About 12% of the men in the placebo group had IIEF scores of 26 or higher. The men who took tadalafil, however, had better results.  Almost 40% of the men in each tadalafil group achieved scores in this range.

The men in the tadalafil groups also had higher rates of intercourse and overall sexual satisfaction. 

“Treatment with tadalafil once daily may be a viable option for men with ED that could help restore normal erectile function,” the researchers concluded.

Please click here for more details on this study.